I acknowledge that all products sold by Aventra Laboratories are intended strictly for laboratory research purposes only
The evidence is limited and frequently from small studies
In obese mice, chronic administration of AOD-9604 was shown to significantly increase 3- adrenergic receptor (3-AR) mRNA expression in both white and brown adipose tissue
Research into tirzepatide alone demonstrates robust weight loss outcomes: clinical trials showed average reductions of 2022% body weight over 68 weeks in patients with obesity
Overall, NAD+ Injection side effects tend to be manageable, and your provider will monitor you, especially during initial doses, to ensure youre responding well
Neurological and Mood Support May assist in management of brain fog , mild depression , and neuropathy Supports mood regulation and mental clarity in high-stress individuals Effective in post-bariatric surgery recovery and nutrient repletion 4